References
Nyman JA. Should the consumption of survivors be included as a cost in cost-utility analysis? Health Econ 2004 May; 13 (5): 417–27
Nyman JA. More on survival consumption costs in cost-utility analysis. Health Econ 2006 Mar; 15 (3): 319–22
Nyman JA. Measurement of QALYs and the welfare implications of survivor consumption and leisure forgone. Health Econ 2011 Jan; 20 (1): 56–67
van Baal PHM, Wong A, Slobbe LCJ, et al. Standardizing the inclusion of indirect medical costs in economic evaluations. Pharmacoeconomics 2011; 29 (3): 175–87
Gold M. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996
Acknowledgements
The authors have no conflicts of interest that are directly relevant to the content of this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nyman, J.A., Jalal, H.J. Including Indirect Medical Care Costs from Survivor Years of Life in Economic Evaluations. Pharmacoeconomics 29, 173–174 (2011). https://doi.org/10.2165/11588790-000000000-00000
Published:
Issue Date:
DOI: https://doi.org/10.2165/11588790-000000000-00000